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Abstract
Impairment of non-cholinergic innervation of
the lower oesophageal sphincter has been
suggested in idiopathic achalasia. As opioid
nerves are present in the lower oesophageal
sphincter and opioid peptides affect lower
oesophageal sphincter motility, the effect ofan
opioid agonist, morphine (100 ,uggkg iv), and an
opioid blocker, naloxone (80 ,ug/kg iv), on
lower oesophageal sphincter motor function
was assessed in 10 healthy subjects and in 10
patients with untreated idiopathic achalasia on
separate days and in randomised order. In
addition, in six ofthe patients, naloxone 0x8 mg
iv was injected 60 minutes after morphine and
recordings continued for a further five minutes.
Lower oesophageal sphincter pressure was
monitored by a sleeve device. In the healthy
subjects morphine decreased (p<0-01) resting
lower oesophageal sphincter pressure by 4 (1)
mm Hg (23 (8)%). In the achalasia patients the
effect was more marked, lower oesophageal
sphincter pressure being reduced (p<001) by
11 (2) mm Hg (46 (8)%). Naloxone reversed
lower oesophageal sphincter pressure to basal.
Both absolute and percentage decreases after
morphine were significantly greater (p<005) in
the achalasia patients than in the healthy sub-
jects. Swallow induced lower oesophageal
sphincter relaxation was significantly
decreased (p<005) by morphine in the healthy
subjects but not in the achalasia patients.
Naloxone had no effect on resting lower oeso-
phageal sphincter pressure or swallow induced
relaxation in either healthy subjects or
achalasia patients. In conclusion achalasia
patients are hypersensitive to the effect of
morphine on resting lower oesophageal sphinc-
ter pressure. This finding is unlikely to be the
result ofa denervation process involving opioid
nerves.
(Gut 1993; 34: 16-20)
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Idiopathic achalasia is a disease ofthe oesophagus
characterised by absent peristalsis, impaired
lower oesophageal sphincter relaxation after
swallows and often a high lower oesophageal
sphincter resting pressure.' Achalasia is thought
to be determined by a visceral neuropathy which
probably involves the vagal preganglionic and
the postganglionic nerve fibres of the oeso-
phagus.2 During the past years the attention has
been focused mainly on the lower oesophageal
sphincter, and some results suggest that non-
cholinergic inhibitory nerves are impaired4
whereas cholinergic innervation is at least partly
preserved.
Opioid nerves have been shown in the
myenteric plexus of normal lower oesophageal
sphincter in man" and various opioid receptors
have been identified in the opossum lower
oesophageal sphincter, in the sphincter muscle
and the nerve fibres surrounding it.'" Further-
more, evidence exists that opioid peptides affect
lower oesophageal sphincter motor function."-'5
In particular one study'4 showed that an opioid
agonist, morphine, administered to healthy
subjects determined a decrease and an opioid
blocker, naloxone, an increase, although modest,
in lower oesophageal sphincter pressure. The
latter finding may suggest that endogenous
opioids contribute to the control of lower
oesophageal sphincter resting pressure.
We reasoned that if opioid nerves are involved
in the denervation process of achalasia, the lower
oesophageal sphincter of these patients would
show hypersensitivity to opioid receptor stimula-
tion induced by morphine and no effect or
hyposensitivity to endogenous opioid blockade
by naloxone. Therefore, we studied the effect of
morphine and naloxone on lower oesophageal
sphincter motor function in 10 patients with
idiopathic achalasia and compared the results
with those obtained in 10 healthy subjects.
Methods
SUBJECTS AND PATIENTS
Ten healthy subjects (aged 19-27 years; eight
men) and 10 patients with untreated idiopathic
achalasia (aged 25-77 years; four men) were
enrolled in the study, which was approved by the
Human Research Review Committee of the
Ospedale Maggiore of Milan. The patients with
achalasia were referred for investigation and
treatment ofdysphagia which had lasted for three
years; 1-10 (median; range). At barium radio-
graph the oesophageal body, which contained no
food residue in any of the patients, had a
maximum diameter of 3 9 cm; 2x5-6*0. Four
patients have lost weight since the onset of their
oesophageal symptoms (3 kg; 0-10). Upper
gastrointestinal endoscopy was performed in all
patients and no lesions were found at the cardias.
Routine oesophageal manometry showed absent
peristalsis in the oesophageal body and abnormal
(<80%) lower oesophageal sphincter relaxation
in response to water swallows.
MANOMETRIC RECORDING TECHNIQUE
Oesophageal motility was monitored using an
assembly of polyvinyl tubes incorporating a
sleeve sensor (Dentsleeve, Belair, Australia).
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more proximally monitored motor activity of the
oesophageal body at levels 2, 7 and 12 cm above
the lower oesophageal sphincter. Furthermore,
one of two side holes at 23 and 28 cm proximal to
the upper margin of the sleeve monitored
swallows in the pharynx in all but four patients.
Each lumen was connected to a pressure trans-
* ducer (model 4-327-I, Sensormedics, Anaheim,
CA, USA) and perfused with distilled water by a
low compliance pneumohydraulic infusion
* pump (Sensormedics, Milan, Italy; response:
*e- >200 mm Hg/s at 0 5 ml/minute) except for the
pharyngeal port, which was water filled, but not
* perfused to avoid stimulation of swallowing. The
* gastric side hole and sleeve were perfused at 0 5
ml/minute, whereas the side holes in the
oesophageal body were perfused at 0 13 ml/
minute in order to minimise the fluid load to the
subject. Signal from the pressure transducers
were processed and recorded on a polygraph
(model R71 1, Sensormedics, Anaheim, CA,halasia USA) at a paper speed of 1 mm/s.
itients
Figure 1: Effect ofmorphine on resting lower oesophageal sphincter (LOS) pressure. Absolute
changes (A) and percentage changes (% A) ofthe LOS pressure in healthy subjects and
achalasta patients are shown in A andB respectively. Horizontal bars represent means.
The 6 cm long sleeve was positioned so that it
straddled the lower oesophageal sphincter. A
side hole 1 cm below the distal margin of the
sleeve recorded intragastric pressure. Side holes
at the upper margin ofthe sleeve and 5 and 10 cm
mm Hg
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Figure 2: Tracing in a healthy subject at the time ofmorphine injection. Morphine had a
minor effect on resting lower oesophageal sphincter (LOS) pressure. A decrease in respiratory
rate may be noted. The broken line indicates intragastric pressure.
EXPERIMENTS
Oesophageal motility was recorded in the
subjects and patients after an overnight fast
during two experiments performed in ran-
e domised order on two separate days, according to
s the same protocol. Each experiment comprised a
30 minute basal period and a 60 minute period
after intravenous injection of either morphine
(100 ,ug/kg) or naloxone (80 ,g/kg) as a bolus.
No observations were obtained after naloxone in
two of the patients, one refused to perform his
second experiment and the other tolerated it
poorly and failed to complete it. In the last six
patients 0-8 mg ofnaloxone was injected iv at the
end of the morphine period and recording con-
tinued for a further five minutes. Although the
small dose ofnaloxone was administered to block
the central nervous system effect of morphine,'6
we felt it of interest to include manometric
tracings after naloxone in the analysis. Further-
more, in six of the healthy subjects and in the
patients who had tolerated water swallows well
during routine manometry (eight) lower
oesophageal sphincter relaxation in response to
six to eight water (5 ml) swallows per period was
assessed. Subjects and patients were recumbent
throughout the experiments.
ANALYSIS OF RECORDS
The pressure tracings were analysed by one ofthe
investigators who was unaware of the drug
tested. The effect of the two drugs on resting
lower oesophageal sphincter pressure was evalu-
ated as follows. Increases in lower oesophageal
sphincter pressure were assessed by comparing
the highest end expiratory lower oesophageal
sphincter pressure occurring during a two
minute interval immediately before drug
administration with the highest end expiratory
pressure occurring one to three minutes after it.
Decreases in lower oesophageal sphincter
pressure were assessed by comparing the lowest
end expiratory lower oesophageal sphincter
pressure occurring during a two minute interval
immediately before drug administration with the
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lowest end expiratory pressure occurring one to
three minutes after it. In addition, the time
course of lower oesophageal sphincter pressure
changes after injection of each drug was
evaluated. For this purpose one minute visual
means of the tracings were measured. Lower
oesophageal sphincter pressure 1, 2, 3, 4 and 5
minutes after drug injection and then at five
minute intervals up to 60 minutes was compared
with the value of the five minutes before injec-
tion. Lower oesophageal sphincter pressure was
referenced to end expiratory intragastric
pressure. Swallow induced relaxations and con-
tractions and artefacts were disregarded in the
analysis. On some occasions, lower oesophageal
sphincter pressure showed increases syn-
chronous with regular gastric contraction waves
and lasting a few minutes, presumably an expres-
sion of late phase 2 and/or phase 3 of the
interdigestive migrating motor complex. 7 These
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periods were not included in the analysis to avoid
an unwanted source of variation. The effect of
the two drugs on swallow induced lower oesopha-
geal sphincter relaxation was evaluated by count-
ing residual lower oesophageal sphincter
pressure and percentage lower oesophageal
sphincter relaxation. To calculate the latter,
lower oesophageal sphincter pressure of the 15
seconds before that swallow was taken as refer-
ence pressure.
STATISTICAL ANALYSIS
Paired and unpaired Student's t tests were used
for statistical analysis of results except for the
time course of lower oesophageal sphincter
pressure changes after drug injection for which
Dunnett's test for multiple comparisons involv-
ing a control mean was used. Results were
expressed as mean (SEM).
Results
The mean dose of morphine was 6-8 mg in the
achalasia patients and 6 6 mg in the healthy
subjects, and the dose of naloxone was 5 6 mg
and 5 3 mg respectively.
Resting lower oesophageal sphincter pressure
in the basal period was significantly higher in the
achalasia patients, 24 (3) mm Hg, than in the
healthy subjects, 16 (1) mm Hg (p<005). In the
latter group morphine determined a decrease of
lower oesophageal sphincter pressure of 4
(1) mm Hg (p<0-01), corresponding to 23 (8)%
(Figs 1, 2). In the achalasia patients morphine
had a more marked effect on lower oesophageal
sphincter pressure, which decreased by 11 (2)
mm Hg (p<001), corresponding to 46 (8)%
(Figs 1, 3). Both absolute and percentage lower
oesophageal sphincter pressure falls were greater
(p<005) in the patients than in the healthy
subjects. Furthermore, analysis of the time
course of lower oesophageal sphincter pressure
changes after morphine (Fig 4) showed that in
the healthy subjects the effect of the drug was
gradually lost and lower oesophageal sphincter
pressure was no longer significantly lower than
before drug injection by 30 minutes. In the
achalasia patients, on the contrary, lower
oesophageal sphincter pressure remained
steadily and significantly (p<0-01) lower than
before drug injection for the whole 60 minute
observation period. In the six patients to whom
naloxone was administered 60 minutes after
morphine lower oesophageal sphincter pressure
increased to values similar to basal ones (p=ns)
by two minutes after injection (Fig 5). Morphine
significantly decreased (p<0O05) swallow
induced lower oesophageal sphincter relaxation
in the healthy subjects, but not in the achalasia
patients (Table). It may be noted that in the
patients lower oesophageal sphincter relaxation
was already very poor in basal conditions and
after morphine it showed a slight further
decrease in only five of the eight patients tested.
Paradoxically, in the patients residual lower
oesophageal sphincter pressure was lower
(p<005) after morphine, a finding which is
explained by the marked effect of the drug on
resting lower oesophageal sphincter pressure.
II I II II N I aI I
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TABLE Percentage lower oesophageal sphincter relaxation
after water swallows in six healthy subjects and eight
achalasia patients
Healthy subjects Achalasia patients
Basal 94 (3) [1 0 (0 5)] 20 (7) [18 (2)]
Morphine 61 (6)* [5-4 (0 7)*] 11 (5) [10 (2)*]
Basal 92 (2) [1 3 (0 3)] 17 (5) [20 (1)]
Naloxone 95 (2) [0 9 (0-4)] 14 (6) [20 (1)]
*=p<0c05 v basal.
Numbers in square brackets represent residual lower oesophageal
sphincter pressure in mm Hg. Data are expressed as mean (SEM).
, , , been stronger if the blocking effect of naloxone30 35 40 45 50 55 60 65 had been shown by injecting the drug before
Time (min after morphine injection) morphine.
i:Mean resting The location of the receptors responsible for
sophageal sphincter the effect of morphine on lower oesophageal
oressure of 6 patients Unlike morphine, naloxone had no effect on sphincter tone cannot be ascertained by ourialasia at the time Of resting lower oesophageal sphincter pressure in experiments. On the one hand it is known from
of the effect of the healthy subjects and achalasia patients (Fig animal studies2"22 that the effects of morphine on
e. The broken line 6). Evaluation of the time course of lower gastrointestinal motility may occur through stim-
smeanLOS oesophageal sphincter pressure changes after ulation of central and peripheral receptors andof thefive mnutes naloxone confirmed this observation, showing that the central component appears to be medi-
that in both groups lower oesophageal sphincter ated by the vagus nerve.20 Furthermore, at the
pressure did not differ significantly from the periphery, receptors sensitive to morphine have
basal value at any of the time points. Swallow been shown at prejunctional sites along
induced lower oesophageal sphincter relaxations cholinergic pathways23 or directly on the smooth
were also unaffected by naloxone in both groups muscle.'0 On the other hand, current evidence
(Table). suggests that in man basal lower oesophageal
sphincter pressure represents the sum of excita-
tory neural activity, inhibitory neural activity,
Discussion and myogenic activity.2425 Thus morphine may
The major finding of the present study was that have acted either along the neural pathways or on
the lower oesophageal sphincter of achalasia the lower oesophageal sphincter muscle itself.
patients responded to intravenous injection of What is the possible physiological interpreta-
morphine with a significantly greater decrease in tion of the greater response of the lower oesopha-
tone than that in healthy subjects. Two lines of geal sphincter in achalasia and what do we gain in
evidence suggest that the effect of morphine on terms of understanding of the pathogenesis of
lower oesophageal sphincter tone was mainly achalasia? This is a problematical point and a few
mediated through a ,u opioid receptor. Firstly, hypotheses may be considered. For example, a
morphine has a high affinity for the /. type among decrease or functional impairment of opioid
the various opioid receptors,'8 and secondly the nerve fibres could determine denervation super-i:Effect of naloxone effect of morphine was almost completely sensitivity to morphine. Although an immuno-gv lower oesophageal reversed by a small dose of naloxone. Although cytochemical study' showing no opioid
cShanges(A)and naloxone at high doses may have pharmaco- containing nerves in the lower oesophagealge changes(% A) logical actions other than opioid antagonism,'" at sphincter in achalasia may support this conten-
pressure in healthy low doses it binds mostly with / receptors.'0 18-19 tion two other observations do not. Firstly,and achalasia
are shon in A and The second argument, however, would have naloxone had no effect on lower oesophageal
tively. Horizontal sphincter motor function in either normals or
resent means. achalasia patients, suggesting that this function is
A p = NS B p= NS not controlled by opioid nerves. It may be
50 argued, however, that, at the high dose we used
when naloxone was tested in basal conditions,
effects other than opioid receptor antagonism
* may have been predominant.'9 Furthermore,
* endogenous opioids may have a physiological
_0+@ o @@ role in the control of lower oesophageal sphincter0~~ ~~~~~
tone only in the fed state when a decrease in lower) * @oesophageal sphincter pressure is known to
v*v va. * occur.26 Secondly, the magnitude of the dif-(8 ference between normal subjects and achalasia0
patients was probably too small for a true
_-50- denervation effect. Comparison between animal
reports on denervation2"'2 and our paper is
difficult. Those studies mainly concerned the
contractile response of the smooth muscle to
adrenergic and cholinergic denervation and the
-100 response of the denervated muscle was somewhat
Healthy Achalasia Healthy Achalasia variable, showing that the same degree of con-
subjects patie'nts subjects patients traction was produced by doses -of the relevant
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agonist, noradrenaline or acetylcholine, from a
few times to a few 10 times smaller than for the
normally innervated muscle. It may nevertheless
be cautiously extrapolated that the effect of
denervation on smooth muscle was generally
greater than the effect of achalasia. Another
explanation for morphine hypersensitivity in
achalasia is impairment of non-opioid nerves
located between the opioid receptor and the
lower oesophageal sphincter muscle, which may
have altered the lower oesophageal sphincter
response. A final hypothesis is the activation of
abnormal compensatory neural mechanisms for
control of lower oesophageal sphincter tone in
achalasia patients, induced by a direct action of
morphine on the lower oesophageal sphincter
muscle.
We think that further studies on peripheral
opioid agonists in achalasia patients may be of
interest for two reasons. Firstly, they may help to
ascertain whether the receptors involved in
morphine hypersensitivity are located within or
outside the central nervous system. Secondly, as
pharmacological treatment of achalasia is rela-
tively inefficacious and often not well tolerated,
they may indicate whether it is worth testing a
small oral dose of a peripheral opioid agonist in
combination with a calcium channel blocker or a
nitrate in order either to achieve a greater
reduction in lower oesophageal sphincter tone by
combining two different relaxing mechanisms,
or to reduce the dose of the traditional drugs.
Whereas our data on morphine confirm that it
decreases basal lower oesophageal sphincter
pressure in normal subjects," '4 those on
naloxone are in apparent partial disagreement
with one study,'4 in which a similar dose deter-
mined a modest increase of lower oesophageal
sphincter pressure. This increase, however, was
only intermittently significant during the 60
minute observation period. Furthermore, the
different criterion of measuring lower oesopha-
geal sphincter pressure with regard to oscillations
related to the interdigestive migrating motor
complex may have contributed to the different
results.
Contrary to our findings on lower oesophageal
sphincter tone, during swallow induced relaxa-
tions the achalasia patients showed a much
smaller response to morphine than the healthy
subjects. A likely hypothesis is that the drug
acted on receptors located at sites different from
those involved in the effect on tone, most prob-
ably along the vagal efferent neural pathways res-
ponsible for swallow induced relaxations.30
These pathways are thought to be severely
damaged by the disease and thus unable to
induce a normal relaxation of the lower oesopha-
geal sphincter or to respond to morphine. Our
results in healthy subjects, confirming inhibition
of swallow induced relaxation by morphine'3 in
spite of a relaxing effect on lower oesophageal
sphincter basal pressure, support this notion of
two different sites of action.
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